Eligibility to COAPT Trial in the Daily Practice: A Real-World Experience

被引：0
|
作者：
Zancanaro, Edoardo [1 ]
机构：
[1] Osped San Raffaele, Milan, Italy
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 80卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-336
引用
收藏
页码：B135 / B136
页数：2
相关论文
共 50 条
  • [21] Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience
    Monzo, L.
    Cicogna, F.
    Tota, C.
    Petronilli, V.
    Mennuni, S.
    De Ruvo, E.
    Calo, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 42 - 43
  • [22] Eligibility and feasibility of hepatitis C treatment in the era of direct-acting antiviral agents: Our experience in real-world practice
    Schiavini, Monica
    Landonio, Simona
    Magni, Carlo
    Passerini, Simone
    Niero, Fosca
    Croci, Alessandro Luciano
    Passerini, Matteo
    Bolis, Matteo
    Gubertini, Guido
    Angeli, Elena
    Mainini, Annalisa
    Giorgi, Riccardo
    Vimercati, Stefania
    Rizzardini, Giuliano
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E238 - E239
  • [23] Real-World Patient Eligibility for Transcatheter Tricuspid Valve Interventions: Translating Trials to Clinical Practice
    Kolte, Dhaval
    Elmariah, Sammy
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (10) : 1273 - 1274
  • [24] Innovation in Real-World Practice
    Shaw, Richard E.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (10): : A9 - A9
  • [25] Real-World Experience with Ofatumumab
    Thomas, K.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 202 - 203
  • [26] Real-world experience - Reply
    Hutchinson, D
    CHEMICAL ENGINEERING PROGRESS, 1998, 94 (03) : 8 - 8
  • [27] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 70
  • [28] Real-world experience with ocrelizumab
    Moss, B.
    Parrotta, E.
    Baldassari, L.
    Planchon, S.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 780 - 781
  • [29] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 31 - 31
  • [30] Ocrelizumab real-world experience
    Moss, B.
    Utigard, E.
    Baldassari, L.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 504 - 505
12345